Minocycline 100mg (Minocycline)

Minocycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This blocks the addition of aminoacyl‑tRNA to the growing peptide chain, producing a bacteriostatic effect that stops bacterial growth and allows the immune system to clear the infection.

The exact dose of Minocycline 100mg is determined by the prescribing clinician based on the infection type, severity, patient age, weight, and renal or hepatic function. Typical adult regimens range from once to twice daily, but the prescriber sets the final schedule.

Minocycline is classified as Pregnancy Category D, indicating evidence of fetal risk. It should be avoided during pregnancy unless the therapeutic benefit justifies the potential harm. Use while breastfeeding is not recommended because the drug passes into breast milk and may affect the infant.

To order Minocycline 100mg, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The most common alternative to Minocycline is doxycycline, another tetracycline. Both share a similar mechanism, but Minocycline often achieves higher tissue concentrations and may be preferred for severe acne or infections resistant to doxycycline. Doxycycline generally has a lower risk of vestibular side effects but may cause more gastrointestinal upset.

Store Minocycline 100mg tablets at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children. Do not refrigerate or freeze the tablets.

Minocycline 100mg is taken orally with a full glass of water. It may be taken with food to reduce gastrointestinal irritation, but avoid concurrent intake of antacids containing aluminum, calcium, magnesium or iron, as they can decrease absorption.

Serious risks include drug‑induced lupus‑like syndrome, Stevens‑Johnson syndrome or toxic epidermal necrolysis, severe hepatic injury, pseudotumor cerebri, and marked vestibular disturbances such as vertigo or ataxia. Patients should seek immediate medical attention if they develop rash, fever, jaundice, severe headache, or visual changes.

Minocycline is contraindicated in patients with known hypersensitivity to tetracyclines, those with severe hepatic impairment, and in pregnant women unless the benefit outweighs the risk. It should also be avoided in children under eight years of age because of permanent tooth discoloration.